BioCryst Pharmaceuticals, Inc. (BCRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 12:53PM EDT. Market open.
| Previous Close | 6.28 |
| Open | 6.20 |
| Bid | 5.36 x 100 |
| Ask | 6.19 x 100 |
| Day's Range | 6.18 - 6.41 |
| 52 Week Range | 4.03 - 8.96 |
| Volume | |
| Avg. Volume | 3,562,262 |
| Market Cap | 1.276B |
| Beta (5Y Monthly) | 1.96 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.07 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.00 |
GuruFocus.comInsider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
Helen Thackray, Chief Research & Development Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 14, 2024.
GuruFocus.comDirector Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
On May 13, 2024, Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 21,940 shares of the company, as reported in a recent SEC Filing.
GuruFocus.comInsider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
Charles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 13, 2024.
© 2024 Yahoo. All rights reserved.